Cover Image
市場調查報告書

肌酸磷酸的中國市場

Investigation Report on China Phosphocreatine Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 332305
出版日期 內容資訊 英文 30 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
肌酸磷酸的中國市場 Investigation Report on China Phosphocreatine Market, 2010-2019
出版日期: 2015年06月04日 內容資訊: 英文 30 Pages
簡介

1997年Alfa Wassermann所開發的肌酸磷酸,在心血管疾病治療藥領域佔有最大的市場佔有率。肌酸磷酸自打入中國市場以來其銷售額急速擴大,2005年不到3000萬人民幣的銷售量,到2014年已達到了13億7000萬人民幣的規模。

本報告提供中國的肌酸磷酸市場規模與今後預測,提供您主要製藥公司及劑型別市場佔有率,銷售價格等資訊。

第1章 肌酸磷酸的相關概念

  • 適應
  • 全球市場的銷售情形

第2章 中國肌酸磷酸的市場簡介

  • 肌酸磷酸的專利及核準情況
  • 主要製藥公司
  • 市場規模

第3章 中國肌酸磷酸銷售情形調查

  • 銷售額
    • 整體銷售額
    • 各地區的銷售額
  • 銷售量
    • 整體銷售量
    • 各地區的銷售數

第4章 中國肌酸磷酸的主要製藥公司市場佔有率調查

  • 以銷售額為準的市場佔有率
  • 以銷售量為準的市場佔有率

第5章 中國肌酸磷酸的劑型的相關調查

  • 劑型別市場佔有率:以銷售額為準
  • 劑型別市場佔有率:以銷售量為準

第6章 中國醫院的肌酸磷酸的標準價格

  • Beijing Lifeshine Pharmaceutical Co., Ltd
  • Hebei Tiancheng Pharmaceutical Co., Ltd
  • Haikou Qili Pharmaceutical Co., Ltd
  • Harbin Bolai Pharmaceutical Co., Ltd
  • Jilin Yinglian Biopharmaceutical Co., Ltd
  • Alfa Wassermann (義大利) (Neoton)

第7章 中國市場中肌酸磷酸的主要製藥公司

  • Beijing Lifeshine Pharmaceutical Co., Ltd
  • Hebei Tiancheng Pharmaceutical Co., Ltd
  • Harbin Bolai Pharmaceutical Co., Ltd
  • Haikou Qili Pharmaceutical Co., Ltd
  • Jilin Yinglian Biopharmaceutical Co., Ltd

第8章 中國肌酸磷酸的市場預測

  • 市場規模的預測
  • 競爭情形的預測
目錄
Product Code: 1506198

The global epidemic trend shows that cardiovascular disease has become one of the serious threats to human health whose incidence and death rate has exceeded that of malignant tumor and leapt to the first. According to the World Health Organization (WHO), about 17 million people die of cardia-cerebrovascular disease, among which 50% die of acute myocardial infarction and cerebral infarction each year in the world. Phosphocreatine, developed by Alfa Wassermann in 1997, has the largest market share compared with other cardiovascular drugs.

According to CRI's survey, phosphocreatine develops fast after entering China with annual sales value rising from less than CNY 30 million in 2005 to CNY 1.37 billion in 2014 and CAGR during the period of 2005-2014 reaching up to 53.7%. Phosphocreatine enjoys a vast demand in China. Beijing Lifeshine Pharmaceutical Co., Ltd, Haikou Qili Pharmaceutical Co., Ltd, Hebei Tiancheng Pharmaceutical Co., Ltd, Harbin Bolai Pharmaceutical Co., Ltd and Jilin Yinglian Biopharmaceutical Co., Ltd all occupy certain shares of the market, among which Jilin Yinglian Biopharmaceutical Co., Ltd has the largest market share of over 40% with sales value in 2014 reaching up to CNY 560 million. However, Alfa Wassermann (Italy), the original developer of phosphocreatine, had a market share less than 3% in China in 2014.

As Chinese people's living standards improve and the population ages, the incidence of cardiovascular will keep increasing and the market size of phosphocreatine in China will keep expanding too.

Readers can get at least the following information through this report:

  • market share of manufacturers of phosphocreatine in Chinese market
  • price of phosphocreatine in Chinese market
  • major manufacturers of phosphocreatine in China
  • share of different dosage forms of phosphocreatine in Chinese market
  • market outlook of phosphocreatine in China

The author suggests the following groups of people purchase this report:

  • manufacturers of drugs for cardiovascular disease
  • investors/ research institutions interested in Chinese medicine market
  • any interest in Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Phosphocreatine

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Phosphocreatine in China

  • 2.1. Patent and Approval Status of Phosphocreatine in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Sales Status of Phosphocreatine in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Manufacturers of Phosphocreatine in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Phosphocreatine in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Phosphocreatine in Chinese Hospitals in 2014

  • 6.1. Beijing Lifeshine Pharmaceutical Co., Ltd
  • 6.2. Hebei Tiancheng Pharmaceutical Co., Ltd
  • 6.3. Haikou Qili Pharmaceutical Co., Ltd
  • 6.4. Harbin Bolai Pharmaceutical Co., Ltd
  • 6.5. Jilin Yinglian Biopharmaceutical Co., Ltd
  • 6.6. Alfa Wassermann (Italy) (Trade Name: Neoton)

7. Major Manufacturers of Phosphocreatine in the Chinese Market, 2010-2014

  • 7.1. Beijing Lifeshine Pharmaceutical Co., Ltd
  • 7.2. Hebei Tiancheng Pharmaceutical Co., Ltd
  • 7.3. Harbin Bolai Pharmaceutical Co., Ltd
  • 7.4. Haikou Qili Pharmaceutical Co., Ltd
  • 7.5. Jilin Yinglian Biopharmaceutical Co., Ltd

8. Market Outlook of Phosphocreatine in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Table of Selected Charts

  • Chart Patent Status of Phosphocreatine in China
  • Chart Approval Information of Phosphocreatine in China
  • Chart Sales Status of Phosphocreatine in China, 2010-2014
  • Chart Sales Value of Phosphocreatine in China, 2010-2014
  • Chart Sales Value of Phosphocreatine in Some Regions in China, 2010-2014
  • Chart Sales Volume of Phosphocreatine in China, 2010-2014
  • Chart Sales Volume of Phosphocreatine in Some Regions in China, 2010-2014
  • Chart Market Share of TOP5 Manufacturers of Phosphocreatine for Sales Value in China, 2010-2014
  • Chart Sales Value and Market Share of Phosphocreatine Made by Harbin Bolai in China, 2010-2014
  • Chart Sales Value and Market Share of Phosphocreatine Made by Hebei Tiancheng in China, 2010-2014
  • Chart Sales Value and Market Share of Phosphocreatine Made by Alfa Wassermann (Italy) in China, 2010-2014
  • Chart Sales Value and Market Share of Phosphocreatine Injection in China, 2010-2014
  • Chart Price of Phosphocreatine Made by Beijing Lifeshine Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Phosphocreatine Made by Hebei Tiancheng Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Phosphocreatine Made by Hebei Tiancheng Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Phosphocreatine Made by Harbin Bolai Pharmaceutical Co., Ltd in Some Chinese Cities in 2014 in Some Chinese Cities in 2014
  • Chart Price of Phosphocreatine Made by Jilin Yinglian Biopharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Phosphocreatine Made by Alfa Wassermann (Italy) in Some Chinese Cities in 2014
Back to Top